<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Hermann Reimer | Activity</title>
	<link>https://www.catswannabecats.com/members/sharonwindow6/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/sharonwindow6/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Hermann Reimer.</description>
	<lastBuildDate>Thu, 25 Jun 2026 06:52:40 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">3d2585be83110dfb1c476848b3104e41</guid>
				<title>Hermann Reimer posted an update: ons can be an indicator of the immune status of the patient. [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/24640/</link>
				<pubDate>Sun, 08 Jun 2025 13:10:48 -0400</pubDate>

									<content:encoded><![CDATA[<p>ons can be an indicator of the immune status of the patient. Not all patients with ocular manifestations have associated features of systemic syphilis. Ocular manifestations can be the first presentation of HIV/AIDS. Although, there is good response to systemic penicillin and HAART, recurrences and immune recovery uveitis (IRU) can also occur.&hellip;<span class="activity-read-more" id="activity-read-more-24640"><a href="https://www.catswannabecats.com/activity/p/24640/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">edc03ddc3b67f44c618b1ac758058bdb</guid>
				<title>Hermann Reimer posted an update: ms that can be activated by 808 nm light excitation sources [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/22385/</link>
				<pubDate>Sat, 07 Jun 2025 12:02:29 -0400</pubDate>

									<content:encoded><![CDATA[<p>ms that can be activated by 808 nm light excitation sources for application in photodynamic therapy. Our nanoplatforms remain photoactive after internalization by living cells, allowing for 808 nm-activated ROS generation. The versatility of our polymer-stabilization strategy promises a straightforward access to other derivatizations (for&hellip;<span class="activity-read-more" id="activity-read-more-22385"><a href="https://www.catswannabecats.com/activity/p/22385/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">59cef7bc8e973c262d30ffc290650c6b</guid>
				<title>Hermann Reimer posted an update: ms that can be activated by 808 nm light excitation sources [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/22370/</link>
				<pubDate>Sat, 07 Jun 2025 11:46:56 -0400</pubDate>

									<content:encoded><![CDATA[<p>ms that can be activated by 808 nm light excitation sources for application in photodynamic therapy. Our nanoplatforms remain photoactive after internalization by living cells, allowing for 808 nm-activated ROS generation. The versatility of our polymer-stabilization strategy promises a straightforward access to other derivatizations (for&hellip;<span class="activity-read-more" id="activity-read-more-22370"><a href="https://www.catswannabecats.com/activity/p/22370/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1176d0ca66b060da58747e8aa8c8830f</guid>
				<title>Hermann Reimer posted an update: 5&#160;±&#160;0.9 [26.8, 30.3] vs 28.5&#160;±&#160;0.6 [27.1, 29.9] ms, P [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/20107/</link>
				<pubDate>Thu, 05 Jun 2025 11:19:35 -0400</pubDate>

									<content:encoded><![CDATA[<p>5&nbsp;±&nbsp;0.9  vs 28.5&nbsp;±&nbsp;0.6  ms, P&nbsp;=&nbsp;0.719) were nonsignificant. T2∗ was significantly increased in the lesion-sided MT vs the LT for the JOCD-affected knees (21.5&nbsp;±&nbsp;0.7  vs 18.0&nbsp;±&nbsp;0.7  ms, P&nbsp;=&nbsp;0.002), but this same difference was also observed between the MT and LT in control knees (21.0&nbsp;±&nbsp;0.6  vs 18.1&nbsp;±&nbsp;1.1  ms, P&nbsp;=&nbsp;0.037). There was no signifi&hellip;<span class="activity-read-more" id="activity-read-more-20107"><a href="https://www.catswannabecats.com/activity/p/20107/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">fd32c957dce0d387ebb035156fc6f5db</guid>
				<title>Hermann Reimer posted an update: The validity of any biomedical study is potentially affected [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/18956/</link>
				<pubDate>Wed, 04 Jun 2025 11:38:40 -0400</pubDate>

									<content:encoded><![CDATA[<p>The validity of any biomedical study is potentially affected by measurement error or misclassification. <a href="https://www.selleckchem.com/products/8-bromo-camp.html" rel="nofollow ugc">selleck</a> It can affect different variables included in a statistical analysis, such as the exposure, the outcome, and confounders, and can result in an overestimation as well as in an underestimation of the relation under investigation. We&hellip;<span class="activity-read-more" id="activity-read-more-18956"><a href="https://www.catswannabecats.com/activity/p/18956/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d2650f8b7f34a372538a5a2c560ac57f</guid>
				<title>Hermann Reimer posted an update: In particular, subgroup analysis indicated that only the [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/15016/</link>
				<pubDate>Mon, 02 Jun 2025 11:41:49 -0400</pubDate>

									<content:encoded><![CDATA[<p>In particular, subgroup analysis indicated that only the interventions carried out individually exerted significant combined effect for lowering IDWG. As for subjective measures, meta-analysis also revealed small but significant combined effects. CONCLUSIONS The results of this meta-analysis suggest that psycho-social and educational interventions&hellip;<span class="activity-read-more" id="activity-read-more-15016"><a href="https://www.catswannabecats.com/activity/p/15016/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">bd132d07d0b422704bbf433532dd8d87</guid>
				<title>Hermann Reimer posted an update: We introduced a humanoid robot for the use of [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/5364/</link>
				<pubDate>Sat, 31 May 2025 14:47:27 -0400</pubDate>

									<content:encoded><![CDATA[<p>We introduced a humanoid robot for the use of techno-psychological distraction techniques in children aged 4-10 to reduce their anxiety and improve their behaviour during dental treatment.</p>
<p> Two hundred children (98 boys, 102 girls; mean age 6.5 ± 1.66 years) appointed for first time for dental caries were included and randomly divide&hellip;<span class="activity-read-more" id="activity-read-more-5364"><a href="https://www.catswannabecats.com/activity/p/5364/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c3464565a538d2d63cc99d2eea718780</guid>
				<title>Hermann Reimer became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/5097/</link>
				<pubDate>Sat, 31 May 2025 14:28:02 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>